Changho Han

Vanderbilt University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (5)

Julie Engers

Research Assistant Professor

Vanderbilt University

UNITED STATES

View details

David Colby

Professor of Medicinal Chemistry

University of Mississippi

UNITED STATES

View details

Samantha McClenahan

Program Lead l Program Head for De-risk Cytokine Release Syndrome

Fraunhofer Institute for Digital Medicine

UNITED STATES

View details

Jonathan Mills

Vanderbilt University School of Medicine

UNITED STATES

View details

Trever Carter

Scripps Research Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Changho Han

Research Interests

Explore related searches

Contact this professor

Articles (8)

Generation of formaldehyde and formaldehyde-d<sub>2</sub> for hydroxymethylations and hydroxydeuteromethylations of difluoroenolates and difluorobenzyl carbanions

Development of <b>VU6019650</b>: A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M<sub>5</sub> Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use Disorder

Discovery of a potent M5 antagonist with improved clearance profile. Part 2: Pyrrolidine amide-based antagonists

Discovery of a potent M5 antagonist with improved clearance profile. Part 1: piperidine amide-based antagonists

VU6036720: The first potent and selective in vitro inhibitor of heteromeric Kir4.1/5.1 inward rectifier potassium channels

DARK Classics in Chemical Neuroscience: Loperamide

Discovery of VU6028418: A Highly Selective and Orally Bioavailable M4 Muscarinic Acetylcholine Receptor Antagonist

Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core

Collaborators (5)

Julie Engers

David Colby

Samantha McClenahan

Jonathan Mills

Trever Carter

Make your next move.